scholarly article | Q13442814 |
P50 | author | Michaela E. McGree | Q114374047 |
Aruna V Sarma | Q114406479 | ||
Steven J Jacobsen | Q37384936 | ||
Lauren P Wallner | Q87807507 | ||
Jennifer L St Sauver | Q88389807 | ||
Debra J. Jacobson | Q114361283 | ||
P2093 | author name string | Hal Morgenstern | |
P2860 | cites work | Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 |
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Obesity and prostate cancer: making sense out of apparently conflicting data | Q31111552 | ||
Dropout in a longitudinal, cohort study of urologic disease in community men. | Q33266615 | ||
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort | Q33937634 | ||
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy | Q34285704 | ||
History of the Rochester Epidemiology Project | Q34374377 | ||
A formula to estimate the approximate surface area if height and weight be known. 1916. | Q34437560 | ||
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer | Q34716253 | ||
Prostate specific antigen best practice statement: 2009 update. | Q35005239 | ||
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis | Q36577688 | ||
Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia | Q38364094 | ||
Prostate cancer screening behavior in men from seven ethnic groups: the fear factor | Q39746464 | ||
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality | Q39781055 | ||
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | Q39876279 | ||
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group | Q42616120 | ||
The association of body mass index and prostate-specific antigen in a population-based study | Q44009101 | ||
Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study | Q44955190 | ||
Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. | Q46781984 | ||
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection | Q46890162 | ||
Modeling the effects of obesity and weight gain on PSA velocity | Q47178479 | ||
The association between body size, prostate volume and prostate-specific antigen | Q47309075 | ||
Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. | Q50610313 | ||
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. | Q52996033 | ||
A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men | Q57540627 | ||
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial | Q58394513 | ||
Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004 | Q64129544 | ||
Estimated lean body mass as an index for normalization of body fluid volumes in humans | Q70664480 | ||
Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia | Q79864112 | ||
P433 | issue | 3 | |
P304 | page(s) | 501-508 | |
P577 | publication date | 2011-01-17 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection | |
P478 | volume | 20 |
Q39090001 | Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone |
Q34007448 | Association of body mass index and prostate cancer mortality |
Q38121736 | Clinical management of obese patients with cancer |
Q35905134 | Establishment of Reference Ranges for Prostate Volume and Annual Prostate Volume Change Rate in Korean Adult Men: Analyses of a Nationwide Screening Population. |
Q45944320 | Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer. |
Q44871735 | Is Body Mass Index the Best Adiposity Measure for Prostate Cancer Risk? Results From a Veterans Affairs Biopsy Cohort |
Q38871813 | Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk |
Q35535396 | Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status |
Q36968554 | Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate |
Q92963543 | Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy |
Q38838157 | Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis |
Q37496282 | Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study |
Q35250119 | Serum prostate specific antigen changes in cynomolgus monkeys (Macaca fascicularis) on a high sugar high fat diet |
Q34823589 | Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making |
Q90253109 | Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen |
Q40052942 | The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy |
Search more.